TARS

Tarsus Pharmaceuticals Inc.

Price

$73.44

return (12m)

36.76%

p/e

-64.11

p/bv

8.59

DIVIDEND YIELD

0.00%

TARS price

Tarsus Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TARS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

30.06%

3 months

15.69%

1 year

36.76%

2 years

177.03%

5 years

207.02%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals TARS

Valuation

P/E

-64.11

Sector -2.19

Industry 1.21

P/BV

8.59

Sector 2.22

Industry 2.11

P/Revenue (PSR)

4.91

Sector 2.01

Industry 0.78

EV/EBITDA

-202.72

Sector -17.81

Industry -25.30

EV/EBIT

-188.08

Sector -26.72

Industry -18.04

P/EBITDA

-103.22

Sector 0.36

Industry 0.18

P/EBIT

-95.45

Sector -3.34

Industry 1.26

P/Total Assets

4.88

Sector 1.23

Industry 0.86

P/Net Current Assets

10.01

Sector -27.35

Industry -12.37

P/Working Capital

7.72

Sector -4.54

Industry -49.48

EPS

-1.08

Sector -0.87

Industry -0.55

BVPS

8.06

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

93.28%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-7.38%

Sector -323.65%

Industry -73.39%

EBIT Margin

-7.96%

Sector -194.57%

Industry -11.94%

Operating Margin

-8.01%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-7.67%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.28

Sector 0.12

Industry 0.22

Profitability

ROE

-13.41%

Sector -33.82%

Industry -37.56%

ROA

-7.61%

Sector -29.63%

Industry -17.56%

ROIC

-102.11%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.20

Sector 1.84

Industry 1.14

Net Debt / EBITDA

29.36

Sector -1.47

Industry -31.86

Net Debt / EBIT

27.23

Sector -1.32

Industry 2.06

Net Debt / Equity

-1.09

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.21

Sector 0.14

Industry 0.51

Equity/Assets

0.57

Sector 0.42

Industry 0.25

Liabilities/Assets

0.43

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

60.44%

Sector -

Industry -

5Y Earnings CAGR

27.44%

Sector -

Industry -

Fundamentals TARS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TARS Tarsus Pharmaceuticals Inc.	$73.44	34.48%	0.00%	-64.11	8.59	-13.41%	-7.67%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TARS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Tarsus Pharmaceuticals

Tarsus Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

10 years

Founded: 2016

2020

Time since IPO - 6 years

20

Employees

Tarsus Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.98 billion, with shareholders equity totaling $346.73 million.

The company employs approximately 20 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Tarsus Pharmaceuticals Inc. reported $606.33 million in revenue, generating net income of $-46.48 million.

Key financial metrics include a P/E ratio of -64.11, a price-to-book (P/B) ratio of 8.59, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TARS.

Market cap

$2.98 billion

Net worth

$346.73 million

$346,730,000.00

Assets

$611.14 million

$611,140,000.00

Total Shares Outstanding

43.00 million

43,000,000

Average Daily Trading Volume

$1.01 million

$1,011,904.00

Sector

Health

Industry

Pharmaceutical Products

TARS

TARS revenue and profits

Financial Results TARS

DRAG THE FRAME TO SEE MORE DATA

TARS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87